Looking for ways to grow your investment portfolio without breaking the bank? You’re in the right place. We’ve been digging into the market to find some promising companies whose stocks are currently trading for less than $10. It might seem like a small price, but these stocks could offer a big opportunity for growth. Let’s take a look at some of the best stocks to buy now under $10.
Key Takeaways
- Hoth Therapeutics is a biopharmaceutical company focused on developing new medicines.
- Ford Motor Company is making big moves in the electric vehicle market and offers a dividend.
- Nokia is a key player in telecommunications infrastructure, important for 5G and future technologies.
- Lam Research provides equipment for making computer chips, a sector driven by AI and digital trends.
- Spotify Technology is improving its profitability through price adjustments and new offerings like audiobooks.
1. Hoth Therapeutics
Hoth Therapeutics (HOTH) is a clinical-stage biopharmaceutical company that’s trying to make a name for itself in areas like cancer, skin issues, and brain problems. They’ve got a few different projects going on, which is good because it means they aren’t putting all their eggs in one basket. Their main focus right now is a topical treatment called HT-001. This is designed to help with skin problems that can pop up when people are getting cancer treatment, specifically from EGFR inhibitors. They’ve submitted paperwork to the European Medicines Agency (EMA) to get their Phase 2 trial rolling in Europe, with plans to start signing up patients there in early 2026.
Beyond that, they’re also working on HT-KIT, a treatment aimed at certain blood cancers and rare disorders. Early results from lab tests showed it could reduce tumors, and the U.S. Food and Drug Administration (FDA) has given it a special designation, called Orphan Drug Designation. This could mean new options for patients with aggressive forms of conditions like systemic mastocytosis or certain leukemias.
What’s interesting is that Hoth is also dipping its toes into the weight loss market with a program developed with the U.S. Department of Veterans Affairs. Plus, they’re using AI tools to speed up their research, which is pretty modern. They’re using a platform that’s supposed to be really good at predicting if a drug can get past the blood-brain barrier, which is important for brain-related treatments.
They have other candidates in the works too, for things like Alzheimer’s and injuries to the brain. While Hoth Therapeutics has some promising developments, it’s important to remember they are still in the early stages of development, which means there’s a good amount of risk involved, but also the potential for big rewards if their treatments prove successful.
2. Ford Motor Company
![]()
Ford Motor Company is a name most people recognize, and for good reason. They’ve been making cars for a long time. Now, they’re really pushing into the electric vehicle (EV) space with their Model e division, while still keeping their traditional gas-powered vehicles going strong. It’s a big shift, and they’re putting a lot of money into it, planning to spend up to $50 billion on EV infrastructure by 2026. They’ve even set a goal of selling 2 million EVs annually by that same year.
Financially, Ford had a pretty good year in 2024, bringing in a record $185 billion in revenue. They’re also trying to give back to shareholders, offering a dividend that’s currently over 6%. This makes them an interesting option for investors looking for both growth potential in EVs and some income from dividends. It’s a bit of a balancing act, but Ford seems committed to making it work. Some analysts are feeling positive about the company’s direction, with one firm recently increasing its price target for Ford (F) shares to $12 from $10.
Here’s a quick look at some key aspects:
- EV Investment: Significant capital being poured into electric vehicle development and manufacturing.
- Dividend Yield: Offers a competitive dividend, appealing to income-focused investors.
- Market Position: Balancing a legacy business with a forward-looking EV strategy.
- Revenue Growth: Achieved record revenue in 2024, indicating strong sales performance.
3. Nokia
Nokia Oyj (NYSE:NOK) is a big name in the telecommunications world, and for good reason. They’re a major player in building out the networks that keep us all connected, especially with the ongoing rollout of 5G and the future development of 6G.
Think of them as the backbone for a lot of the communication infrastructure we rely on. They work with service providers, businesses, and even governments to get these networks up and running. It’s not just about phones anymore; it’s about the whole system that makes everything from streaming to business operations possible.
Lately, Nokia’s been showing some positive financial signs. They’ve been exceeding earnings expectations, and their outlook for the coming year looks pretty good. They’re also focused on returning money to shareholders through things like share buybacks and increasing dividends. This focus on both operational improvement and shareholder returns makes Nokia an interesting company to watch in the telecom space.
Here’s a quick look at their business areas:
- Network Infrastructure: This is their core business, providing equipment and services for mobile and fixed networks.
- Cloud and Network Services: Helping businesses manage and optimize their network operations.
- Nokia Enterprise: Offering solutions for various industries beyond traditional telecom.
- Nokia Technologies: Managing the company’s intellectual property and licensing.
Analysts seem to be feeling good about Nokia too, with many recommending it as a buy. It seems like a solid choice for those looking for a company involved in the essential infrastructure of our digital lives. You can check out the latest analyst ratings for Nokia stock to get a clearer picture.
4. Lam Research
Lam Research (LRCX) is a big player in the technology sector, making the equipment that’s used to manufacture semiconductors. You know, the tiny chips that power everything from your phone to supercomputers. The company’s stock took a bit of a hit recently due to some export restrictions on chip tech and a competitor’s not-so-great performance. But honestly, that might be a good chance for folks looking to get in.
The demand for semiconductors is only going to keep climbing, especially with artificial intelligence becoming more and more common and everything else getting more digital. Analysts are predicting solid earnings growth for Lam Research over the next couple of years. Even with its recent recovery, the stock is trading at a price that’s actually a bit lower than what you’d typically expect for a company in this specific part of the semiconductor industry. It’s trading around 34 times its expected 2025 profits, which seems pretty reasonable when you look at others making similar gear.
Here’s a quick look at some key figures:
- Market Value: Around $203.7 billion
- Dividend Yield: About 0.6%
- Sector: Technology
Basically, Lam Research is in a business that’s pretty central to where technology is heading. While there have been some bumps, the long-term outlook seems pretty strong because we’re just using more and more advanced electronics.
5. Spotify Technology
Spotify Technology, the big name in music streaming, is really starting to show some financial muscle. After a pretty wild ride where its stock price more than doubled last year, the company is making some smart moves. They’ve been raising prices, which they hadn’t done much of before, and cutting costs by reducing their workforce a bit. Plus, they’re adding new things like audiobooks and bundled services to bring in more money.
One analyst from Morgan Stanley still has a positive outlook, seeing potential for the stock to go up even more. They think the price increases, along with new content and the general buzz around AI, will keep the revenue growing. It seems like Spotify is kicking off a new phase of growth, especially with how they’ve improved their free and paid options. It’s interesting to see how they’re turning things around financially. If you’re curious about how its valuation stacks up, you can check out fair value estimates for a deeper look.
6. Becton, Dickinson
Becton, Dickinson, often just called BD, is a big name in the healthcare world. They make a lot of the disposable medical supplies that hospitals and clinics use every single day. Think about things like syringes, IV equipment, and surgical tools – BD is likely involved in making them. What’s interesting about this company is how much of their business comes from repeat customers. Around 85% of their income is from products that get used up and need to be replaced regularly. It’s kind of like how razor companies make money from selling blades over and over.
This steady stream of income has helped BD stay pretty stable, even when other medical device companies have had a tougher time. While their business might have been flat recently, it didn’t really drop. Right now, the stock is trading at a price that seems pretty reasonable when you look at what they’re expected to earn in the coming years. It’s actually a bit cheaper than it has been historically, and also cheaper compared to similar companies in the healthcare sector. Analysts are predicting some growth in their earnings over the next year or so. Plus, they pay out a dividend, which is a nice little bonus for shareholders. The company’s fair value is estimated to be around $206.58, suggesting a positive outlook for the stock Becton Dickinson’s fair value.
Here’s a quick look at some key figures:
- Sector: Health Care
- Market Value: Approximately $50.9 billion
- Dividend Yield: Around 2.4%
- Revenue Source: About 85% recurring revenue from single-use products.
7. Fiserv
Fiserv, a company that handles information management and e-commerce systems for the financial services sector, has seen a pretty rough year. Shares have dropped quite a bit over the last 12 months, and Wall Street seems to be taking a step back. Even though analysts have set a target price that suggests a good amount of upside, it’s not expected to be a smooth ride.
Recently, Fiserv missed third-quarter expectations and had to lower its full-year guidance. This led one analyst to cut their rating on the stock. The company pointed to a few things for this slowdown, including conditions in Argentina, adjustments to their initial forecasts, necessary investments, and stepping back from some short-term projects. It seems like confidence in the company’s growth story will need some time to rebuild before the stock can really bounce back.
Here’s a quick look at some key figures:
- Sector: Financials
- Market Value: $33.1 billion
- Dividend Yield: N/A
8. Vertiv Holdings
Vertiv Holdings (VRT) is a company that works behind the scenes to keep our digital world running. They focus on digital infrastructure, which basically means they make the stuff that powers big data centers and the computers crunching numbers for AI. Think of them as the folks who build the plumbing for the internet’s biggest buildings.
What’s interesting is how they approach cooling. Instead of just blowing cold air, Vertiv offers liquid cooling systems. These systems use a fluid loop to manage heat, and they’re apparently more efficient, using less electricity. This also means computers can be packed closer together, which is a big deal when you’re talking about massive data centers. While some new cooling tech is popping up, Vertiv seems to be in a good spot because they aren’t directly competing with every new idea. Plus, they’ve teamed up with Nvidia, which could mean a nice boost in sales and profits.
Vertiv’s stock took a bit of a dip recently after a big run-up, so it’s trading at a higher price relative to its expected earnings. Some analysts see potential for the stock to go up from here, but it’s definitely something to look into closely.
Here’s a quick look at some key points:
- Focus: Digital infrastructure and data center cooling solutions.
- Technology: Offers advanced liquid cooling systems, aiming for better efficiency.
- Partnerships: A recent collaboration with Nvidia could drive future growth.
- Market Position: Specializes in components that keep large-scale computing operations running smoothly.
9. Envue
Alright, let’s talk about Envue. This is a company that’s been flying a bit under the radar, but it’s worth a look, especially if you’re hunting for those under-$10 gems. Envue operates in the consumer staples sector, which is generally pretty stable, even when the broader market gets a bit shaky. Think of it as the kind of company that sells everyday stuff people need, no matter what’s going on.
The big news recently is that Envue is set to be acquired by Kimberly-Clark. This is a pretty significant development. For Envue shareholders, this means they’ll be getting a mix of cash and Kimberly-Clark stock. Based on recent prices, the deal values Envue at around $48.7 billion. It’s a move that shows the value of Envue’s brands, which include well-known names like Tylenol, Band-Aid, and Neutrogena. These are products many of us use regularly.
Before the acquisition news, Envue was trading at a price that some analysts thought was a bargain. They pointed out that the company’s stock was trading at about 16 times its expected profits for 2025. That’s considered pretty low for a company with such a solid portfolio of brands. The idea was that with a bit of strategic focus, especially in areas like skincare, Envue could see better growth. Analysts were projecting revenue to grow by 3% to 4% annually, with earnings climbing a bit faster, maybe 6% to 8%.
Here’s a quick look at what the deal means:
- Acquirer: Kimberly-Clark (KMB)
- Target: Envue (KVUE)
- Deal Value: Approximately $48.7 billion
- Shareholder Payout: Cash plus Kimberly-Clark shares
Even though the acquisition is happening, it’s a good reminder that sometimes solid companies with strong brands can be overlooked. The deal is expected to close once all the approvals are in place. It’s a situation where the potential benefits of Envue’s business will now likely go to Kimberly-Clark’s shareholders. Keep an eye on how this plays out, as it could be a good example of value being recognized in the consumer staples space.
10. Goldman Sachs
Goldman Sachs (GS) is a big name in the financial world, and it looks like 2025 could be a good year for them. Investment banks, in general, had a decent run in 2024, and some folks think things will get even better next year, partly because more companies might start selling shares to the public (IPOs).
Even with some market uncertainty floating around, Goldman Sachs has a few things going for it. Their wealth management business has been doing really well, bringing in record fees last year. Plus, the amount of money they manage hit a new high of $3 trillion.
All this good news has pushed the stock up quite a bit over the past year, and it seems to be picking up speed along with the rest of the market.
Here’s a quick look at some numbers:
| Metric | Value |
|---|---|
| Sector | Financials |
| Market Value | $236.3 billion |
| Dividend Yield | 2.0% |
| P/E Ratio (2025 est.) | 16x |
Analysts are expecting earnings to grow by about 20% annually in 2025. It’s a well-established company, and while it’s not exactly a penny stock, it’s a major player in the financial sector that’s showing some solid momentum.
Wrapping It Up
So, we’ve looked at some stocks that are currently trading for less than ten bucks. It’s easy to think that cheap stocks mean cheap opportunities, but that’s not always the case. Some of these companies might be small now, but they’ve got plans to grow. Remember, though, investing in these kinds of stocks can be a bit of a gamble. They’re not for everyone, and you should always do your own homework before putting any money down. Think about what you can afford to lose and how long you’re willing to wait to see if these companies pan out. It’s about finding what fits your own money situation, not just chasing the lowest price.
Frequently Asked Questions
What are stocks under $10?
Stocks under $10 are shares of companies that trade for less than ten dollars each. These are often called ‘penny stocks,’ and while they can be risky, they also offer a chance for big gains if the company does well. They can be a good way to start investing without spending a lot of money.
Why would someone buy stocks under $10?
People buy stocks under $10 because they can afford to buy more shares for the same amount of money. If the stock price goes up even a little bit, the percentage gain can be quite large. It’s a way to potentially grow your money faster, but it also means you could lose money faster if things go wrong.
Are stocks under $10 safe to buy?
Stocks under $10 are generally considered more risky than stocks from larger, well-established companies. Their prices can jump up or down very quickly. It’s important to do your homework and understand the risks before investing in them. They might be better suited for people who are comfortable with taking on more risk.
How can I find good stocks under $10?
Finding good stocks under $10 involves research. Look for companies that have solid plans for the future, are in growing industries, or have recently faced challenges but are expected to bounce back. Reading financial news and analyst reports can help you spot potential opportunities.
What is a ‘Strong Buy’ rating?
A ‘Strong Buy’ rating from stock market experts means they believe a particular stock is a very good investment right now and is likely to increase significantly in value over time. It’s a sign of confidence from people who study the stock market for a living.
Should I invest all my money in stocks under $10?
It’s generally not a good idea to put all your investment money into just one type of stock, especially riskier ones like those under $10. It’s usually best to spread your money across different kinds of investments to lower your overall risk. Think of these stocks as a small part of a bigger investment plan.
